4//SEC Filing
Pandite Arundathy N. 4
Accession 0000950170-24-004648
CIK 0001680367other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:31 PM ET
Size
8.4 KB
Accession
0000950170-24-004648
Insider Transaction Report
Form 4
Pandite Arundathy N.
Chief Medical Officer
Transactions
- Award
Common Stock
2024-01-10+46,475→ 222,267 total - Tax Payment
Common Stock
2024-01-10$10.09/sh−2,987$30,139→ 219,280 total - Award
Stock Option (Right to Buy)
2024-01-10+92,950→ 92,950 totalExercise: $10.09Exp: 2034-01-10→ Common Stock (92,950 underlying)
Footnotes (2)
- [F1]Consists of 46,475 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2025, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represents a right to purchase a total of 92,950 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2025, with the remaining three quarters vesting in equal monthly installments through January 10, 2028, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Shattuck Labs, Inc.
CIK 0001680367
Entity typeother
Related Parties
1- filerCIK 0001827232
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 4:31 PM ET
- Size
- 8.4 KB